- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The global Rare Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Rare Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Rare Disease Drug market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Rare Disease Drug market has been segmented into Above 1‰, 0.65‰_1‰, Below 0.1‰, etc.
Breakdown by Application, Rare Disease Drug has been segmented into Hospital Pharmacies, Speciality Pharmacies, Retail pharmacies, Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Rare Disease Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Rare Disease Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Rare Disease Drug market.
For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Rare Disease Drug Market Share Analysis
Rare Disease Drug competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Rare Disease Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Rare Disease Drug sales, revenue and market share for each player covered in this report.
The major players covered in Rare Disease Drug are: Novartis AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Alexion Pharmaceuticals, Inc., Celgene Corporation, AstraZeneca, Sanofi S.A., Pfizer, Inc., Novo Nordisk A/S, Merck & Co., Inc., Takeda, Eisai Co., Ltd., Deciphera, Johnson & Johnson, GlaxoSmithKline, Daiichi Sankyo Company Limited, Amgen, Inc., Biogen, Inc., Bayer AG, Atara Biotherapeutics, ProQR, etc. Among other players domestic and global, Rare Disease Drug market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Rare Disease Drug market are listed below:
Novartis AG
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Alexion Pharmaceuticals, Inc.
Celgene Corporation
AstraZeneca
Sanofi S.A.
Pfizer, Inc.
Novo Nordisk A/S
Merck & Co., Inc.
Takeda
Eisai Co., Ltd.
Deciphera
Johnson & Johnson
GlaxoSmithKline
Daiichi Sankyo Company Limited
Amgen, Inc.
Biogen, Inc.
Bayer AG
Atara Biotherapeutics
ProQR
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Above 1‰
0.65‰_1‰
Below 0.1‰
Market segment by Application, can be divided into
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Rare Disease Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rare Disease Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Above 1‰
1.2.3 0.65‰_1‰
1.2.4 Below 0.1‰
1.3 Market Analysis by Application
1.3.1 Overview: Global Rare Disease Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Speciality Pharmacies
1.3.4 Retail pharmacies
1.3.5 Others
1.4 Global Rare Disease Drug Market Size and Forecast (2015-2025)
1.4.1 Global Rare Disease Drug Revenue and Forecast (2015-2025)
1.4.2 Global Rare Disease Drug Sales and Forecast (2015-2025)
1.5 Global Rare Disease Drug Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis AG SWOT Analysis
2.1.4 Novartis AG Product and Services
2.1.5 Novartis AG Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly and Company
2.2.1 Eli Lilly and Company Details
2.2.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eli Lilly and Company SWOT Analysis
2.2.4 Eli Lilly and Company Product and Services
2.2.5 Eli Lilly and Company Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 F. Hoffmann-La Roche Ltd.
2.3.1 F. Hoffmann-La Roche Ltd. Details
2.3.2 F. Hoffmann-La Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.3.4 F. Hoffmann-La Roche Ltd. Product and Services
2.3.5 F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bristol-Myers Squibb Company
2.4.1 Bristol-Myers Squibb Company Details
2.4.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bristol-Myers Squibb Company SWOT Analysis
2.4.4 Bristol-Myers Squibb Company Product and Services
2.4.5 Bristol-Myers Squibb Company Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Alexion Pharmaceuticals, Inc.
2.5.1 Alexion Pharmaceuticals, Inc. Details
2.5.2 Alexion Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Alexion Pharmaceuticals, Inc. SWOT Analysis
2.5.4 Alexion Pharmaceuticals, Inc. Product and Services
2.5.5 Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Celgene Corporation
2.6.1 Celgene Corporation Details
2.6.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Celgene Corporation SWOT Analysis
2.6.4 Celgene Corporation Product and Services
2.6.5 Celgene Corporation Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 AstraZeneca SWOT Analysis
2.7.4 AstraZeneca Product and Services
2.7.5 AstraZeneca Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi S.A.
2.8.1 Sanofi S.A. Details
2.8.2 Sanofi S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sanofi S.A. SWOT Analysis
2.8.4 Sanofi S.A. Product and Services
2.8.5 Sanofi S.A. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer, Inc.
2.9.1 Pfizer, Inc. Details
2.9.2 Pfizer, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer, Inc. SWOT Analysis
2.9.4 Pfizer, Inc. Product and Services
2.9.5 Pfizer, Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novo Nordisk A/S
2.10.1 Novo Nordisk A/S Details
2.10.2 Novo Nordisk A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Novo Nordisk A/S SWOT Analysis
2.10.4 Novo Nordisk A/S Product and Services
2.10.5 Novo Nordisk A/S Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Merck & Co., Inc.
2.11.1 Merck & Co., Inc. Details
2.11.2 Merck & Co., Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Merck & Co., Inc. SWOT Analysis
2.11.4 Merck & Co., Inc. Product and Services
2.11.5 Merck & Co., Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Takeda SWOT Analysis
2.12.4 Takeda Product and Services
2.12.5 Takeda Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Eisai Co., Ltd.
2.13.1 Eisai Co., Ltd. Details
2.13.2 Eisai Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Eisai Co., Ltd. SWOT Analysis
2.13.4 Eisai Co., Ltd. Product and Services
2.13.5 Eisai Co., Ltd. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Deciphera
2.14.1 Deciphera Details
2.14.2 Deciphera Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Deciphera SWOT Analysis
2.14.4 Deciphera Product and Services
2.14.5 Deciphera Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Johnson & Johnson
2.15.1 Johnson & Johnson Details
2.15.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Johnson & Johnson SWOT Analysis
2.15.4 Johnson & Johnson Product and Services
2.15.5 Johnson & Johnson Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 GlaxoSmithKline
2.16.1 GlaxoSmithKline Details
2.16.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 GlaxoSmithKline SWOT Analysis
2.16.4 GlaxoSmithKline Product and Services
2.16.5 GlaxoSmithKline Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Daiichi Sankyo Company Limited
2.17.1 Daiichi Sankyo Company Limited Details
2.17.2 Daiichi Sankyo Company Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Daiichi Sankyo Company Limited SWOT Analysis
2.17.4 Daiichi Sankyo Company Limited Product and Services
2.17.5 Daiichi Sankyo Company Limited Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Amgen, Inc.
2.18.1 Amgen, Inc. Details
2.18.2 Amgen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Amgen, Inc. SWOT Analysis
2.18.4 Amgen, Inc. Product and Services
2.18.5 Amgen, Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Biogen, Inc.
2.19.1 Biogen, Inc. Details
2.19.2 Biogen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Biogen, Inc. SWOT Analysis
2.19.4 Biogen, Inc. Product and Services
2.19.5 Biogen, Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Bayer AG
2.20.1 Bayer AG Details
2.20.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Bayer AG SWOT Analysis
2.20.4 Bayer AG Product and Services
2.20.5 Bayer AG Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.21 Atara Biotherapeutics
2.21.1 Atara Biotherapeutics Details
2.21.2 Atara Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Atara Biotherapeutics SWOT Analysis
2.21.4 Atara Biotherapeutics Product and Services
2.21.5 Atara Biotherapeutics Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.22 ProQR
2.22.1 ProQR Details
2.22.2 ProQR Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 ProQR SWOT Analysis
2.22.4 ProQR Product and Services
2.22.5 ProQR Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Rare Disease Drug Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Rare Disease Drug Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Rare Disease Drug Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: China
3.2.1 Key Players Rare Disease Drug Sales in China (2018-2019)
3.2.2 China Rare Disease Drug Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Rare Disease Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Rare Disease Drug Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Rare Disease Drug Market Size by Geography (2015-2020)
4.1.1 Global Rare Disease Drug Sales by Geography (2015-2020)
4.1.2 Global Rare Disease Drug Revenue by Regions (2015-2020)
4.2 Global Rare Disease Drug Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Rare Disease Drug Sales and Forecast by Regions (2020-2025)
4.2.2 Global Rare Disease Drug Revenue and Forecast by Regions (2020-2025)
4.3 North America Rare Disease Drug Market Size and Forecast (2015-2025)
4.4 Europe Rare Disease Drug Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Rare Disease Drug Market Size and Forecast (2015-2025)
4.6 South America Rare Disease Drug Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Rare Disease Drug Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Rare Disease Drug Market Size by Country (2015-2020)
5.1.1 North America Rare Disease Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Rare Disease Drug Revenue and Market Share by Country (2015-2020)
5.2 North America Rare Disease Drug Market Size and Forecast by Country (2020-2025)
5.2.1 North America Rare Disease Drug Sales and Forecast by Country (2020-2025)
5.2.2 North America Rare Disease Drug Revenue and Forecast by Country (2020-2025)
5.3 United States Rare Disease Drug Market Size and Forecast (2015-2025)
5.4 Canada Rare Disease Drug Market Size and Forecast (2015-2025)
5.5 Mexico Rare Disease Drug Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Rare Disease Drug Market Size by Country (2015-2020)
6.1.1 Europe Rare Disease Drug Sales by Country (2015-2020)
6.1.2 Europe Rare Disease Drug Revenue by Country (2015-2020)
6.2 Europe Rare Disease Drug Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Rare Disease Drug Sales and Forecast by Country (2020-2025)
6.2.2 Europe Rare Disease Drug Revenue and Forecast by Country (2020-2025)
6.3 Germany Rare Disease Drug Market Size and Forecast (2015-2025)
6.4 United Kingdom Rare Disease Drug Market Size and Forecast (2015-2025)
6.5 France Rare Disease Drug Market Size and Forecast (2015-2025)
6.6 Russia Rare Disease Drug Market Size and Forecast (2015-2025)
6.7 Italy Rare Disease Drug Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Rare Disease Drug Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Rare Disease Drug Sales by Region (2015-2020)
7.1.2 Asia-Pacific Rare Disease Drug Revenue by Region (2015-2020)
7.2 Asia-Pacific Rare Disease Drug Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Rare Disease Drug Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Rare Disease Drug Revenue and Forecast by Region (2020-2025)
7.3 China Rare Disease Drug Market Size and Forecast (2015-2025)
7.4 Japan Rare Disease Drug Market Size and Forecast (2015-2025)
7.5 Korea Rare Disease Drug Market Size and Forecast (2015-2025)
7.6 India Rare Disease Drug Market Size and Forecast (2015-2025)
7.7 Southeast Asia Rare Disease Drug Market Size and Forecast (2015-2025)
7.8 Australia Rare Disease Drug Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Rare Disease Drug Market Size by Country (2015-2020)
8.1.1 South America Rare Disease Drug Sales by Country (2015-2020)
8.1.2 South America Rare Disease Drug Revenue by Country (2015-2020)
8.2 South America Rare Disease Drug Market Size and Forecast by Country (2020-2025)
8.2.1 South America Rare Disease Drug Sales and Forecast by Country (2020-2025)
8.2.2 South America Rare Disease Drug Revenue and Forecast by Country (2020-2025)
8.3 Brazil Rare Disease Drug Market Size and Forecast (2015-2025)
8.4 Argentina Rare Disease Drug Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Rare Disease Drug Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Rare Disease Drug Sales by Country (2015-2020)
9.1.2 Middle East & Africa Rare Disease Drug Revenue by Country (2015-2020)
9.2 Middle East & Africa Rare Disease Drug Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Rare Disease Drug Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Rare Disease Drug Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Rare Disease Drug Market Size and Forecast (2015-2025)
9.4 Turkey Rare Disease Drug Market Size and Forecast (2015-2025)
9.5 Egypt Rare Disease Drug Market Size and Forecast (2015-2025)
9.6 South Africa Rare Disease Drug Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Rare Disease Drug Market Size by Type (2015-2020)
10.1.1 Global Rare Disease Drug Sales by Type (2015-2020)
10.1.2 Global Rare Disease Drug Revenue by Type (2015-2020)
10.1.3 Global Rare Disease Drug Price by Type (2015-2020)
10.2 Global Rare Disease Drug Market Size and Forecast by Type (2020-2025)
10.2.1 Global Rare Disease Drug Sales and Forecast by Type (2020-2025)
10.2.2 Global Rare Disease Drug Revenue and Forecast by Type (2020-2025)
10.2.3 Global Rare Disease Drug Price and Forecast by Type (2020-2025)
10.3 China Rare Disease Drug Market Size and Forecast by Type (2015-2025)
10.3.1 China Rare Disease Drug Market Size by Type (2015-2020)
10.3.2 China Rare Disease Drug Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Rare Disease Drug Market Size by Application (2015-2020)
11.1.1 Global Rare Disease Drug Sales by Application (2015-2020)
11.1.2 Global Rare Disease Drug Revenue by Application (2015-2020)
11.1.3 Global Rare Disease Drug Price by Application (2015-2020)
11.2 Global Rare Disease Drug Market Size and Forecast by Application (2020-2025)
11.2.1 Global Rare Disease Drug Sales and Forecast by Application (2020-2025)
11.2.2 Global Rare Disease Drug Revenue and Forecast by Application (2020-2025)
11.2.3 Global Rare Disease Drug Price and Forecast by Application (2020-2025)
11.3 China Rare Disease Drug Market Size and Forecast by Application (2015-2025)
11.3.1 China Rare Disease Drug Market Size by Application (2015-2020)
11.3.2 China Rare Disease Drug Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Rare Disease Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Rare Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Rare Disease Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Rare Disease Drug Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 6. Novartis AG Rare Disease Drug Major Business
Table 7. Novartis AG Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 8. Novartis AG SWOT Analysis
Table 9. Novartis AG Rare Disease Drug Product and Services
Table 10. Novartis AG Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 12. Eli Lilly and Company Rare Disease Drug Major Business
Table 13. Eli Lilly and Company Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 14. Eli Lilly and Company SWOT Analysis
Table 15. Eli Lilly and Company Rare Disease Drug Product and Services
Table 16. Eli Lilly and Company Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 18. F. Hoffmann-La Roche Ltd. Rare Disease Drug Major Business
Table 19. F. Hoffmann-La Roche Ltd. Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 20. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 21. F. Hoffmann-La Roche Ltd. Rare Disease Drug Product and Services
Table 22. F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 24. Bristol-Myers Squibb Company Rare Disease Drug Major Business
Table 25. Bristol-Myers Squibb Company Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 26. Bristol-Myers Squibb Company SWOT Analysis
Table 27. Bristol-Myers Squibb Company Rare Disease Drug Product and Services
Table 28. Bristol-Myers Squibb Company Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. Alexion Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 30. Alexion Pharmaceuticals, Inc. Rare Disease Drug Major Business
Table 31. Alexion Pharmaceuticals, Inc. Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 32. Alexion Pharmaceuticals, Inc. SWOT Analysis
Table 33. Alexion Pharmaceuticals, Inc. Rare Disease Drug Product and Services
Table 34. Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 36. Celgene Corporation Rare Disease Drug Major Business
Table 37. Celgene Corporation Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 38. Celgene Corporation SWOT Analysis
Table 39. Celgene Corporation Rare Disease Drug Product and Services
Table 40. Celgene Corporation Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 42. AstraZeneca Rare Disease Drug Major Business
Table 43. AstraZeneca Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 44. AstraZeneca SWOT Analysis
Table 45. AstraZeneca Rare Disease Drug Product and Services
Table 46. AstraZeneca Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 48. Sanofi S.A. Rare Disease Drug Major Business
Table 49. Sanofi S.A. Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 50. Sanofi S.A. SWOT Analysis
Table 51. Sanofi S.A. Rare Disease Drug Product and Services
Table 52. Sanofi S.A. Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Pfizer, Inc. Rare Disease Drug Major Business
Table 55. Pfizer, Inc. Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 56. Pfizer, Inc. SWOT Analysis
Table 57. Pfizer, Inc. Rare Disease Drug Product and Services
Table 58. Pfizer, Inc. Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 59. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 60. Novo Nordisk A/S Rare Disease Drug Major Business
Table 61. Novo Nordisk A/S Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 62. Novo Nordisk A/S SWOT Analysis
Table 63. Novo Nordisk A/S Rare Disease Drug Product and Services
Table 64. Novo Nordisk A/S Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 65. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 66. Merck & Co., Inc. Rare Disease Drug Major Business
Table 67. Merck & Co., Inc. Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 68. Merck & Co., Inc. SWOT Analysis
Table 69. Merck & Co., Inc. Rare Disease Drug Product and Services
Table 70. Merck & Co., Inc. Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 71. Takeda Basic Information, Manufacturing Base and Competitors
Table 72. Takeda Rare Disease Drug Major Business
Table 73. Takeda Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 74. Takeda SWOT Analysis
Table 75. Takeda Rare Disease Drug Product and Services
Table 76. Takeda Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 77. Eisai Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 78. Eisai Co., Ltd. Rare Disease Drug Major Business
Table 79. Eisai Co., Ltd. Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 80. Eisai Co., Ltd. SWOT Analysis
Table 81. Eisai Co., Ltd. Rare Disease Drug Product and Services
Table 82. Eisai Co., Ltd. Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 83. Deciphera Basic Information, Manufacturing Base and Competitors
Table 84. Deciphera Rare Disease Drug Major Business
Table 85. Deciphera Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 86. Deciphera SWOT Analysis
Table 87. Deciphera Rare Disease Drug Product and Services
Table 88. Deciphera Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 89. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 90. Johnson & Johnson Rare Disease Drug Major Business
Table 91. Johnson & Johnson Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 92. Johnson & Johnson SWOT Analysis
Table 93. Johnson & Johnson Rare Disease Drug Product and Services
Table 94. Johnson & Johnson Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 95. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 96. GlaxoSmithKline Rare Disease Drug Major Business
Table 97. GlaxoSmithKline Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 98. GlaxoSmithKline SWOT Analysis
Table 99. GlaxoSmithKline Rare Disease Drug Product and Services
Table 100. GlaxoSmithKline Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 101. Daiichi Sankyo Company Limited Basic Information, Manufacturing Base and Competitors
Table 102. Daiichi Sankyo Company Limited Rare Disease Drug Major Business
Table 103. Daiichi Sankyo Company Limited Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 104. Daiichi Sankyo Company Limited SWOT Analysis
Table 105. Daiichi Sankyo Company Limited Rare Disease Drug Product and Services
Table 106. Daiichi Sankyo Company Limited Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 107. Amgen, Inc. Rare Disease Drug Type and Application
Table 108. Amgen, Inc. Rare Disease Drug Major Business
Table 109. Amgen, Inc. Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 110. Amgen, Inc. SWOT Analysis
Table 111. Amgen, Inc. Rare Disease Drug Product and Services
Table 112. Amgen, Inc. Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 113. Biogen, Inc. Basic Information, Manufacturing Base and Competitors
Table 114. Biogen, Inc. Rare Disease Drug Major Business
Table 115. Biogen, Inc. Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 116. Biogen, Inc. SWOT Analysis
Table 117. Biogen, Inc. Rare Disease Drug Product and Services
Table 118. Biogen, Inc. Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 119. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 120. Bayer AG Rare Disease Drug Major Business
Table 121. Bayer AG Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 122. Bayer AG SWOT Analysis
Table 123. Bayer AG Rare Disease Drug Product and Services
Table 124. Bayer AG Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 125. Atara Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 126. Atara Biotherapeutics Rare Disease Drug Major Business
Table 127. Atara Biotherapeutics Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 128. Atara Biotherapeutics SWOT Analysis
Table 129. Atara Biotherapeutics Rare Disease Drug Product and Services
Table 130. Atara Biotherapeutics Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 131. ProQR Basic Information, Manufacturing Base and Competitors
Table 132. ProQR Rare Disease Drug Major Business
Table 133. ProQR Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 134. ProQR SWOT Analysis
Table 135. ProQR Rare Disease Drug Product and Services
Table 136. ProQR Rare Disease Drug Sales (K Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 137. Global Rare Disease Drug Sales by Manufacturer (2018-2019) (K Doses)
Table 138. Global Rare Disease Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 139. Key Players Rare Disease Drug Sales in China (2018-2019) (K Doses)
Table 140. Key Players Rare Disease Drug Sales Market Share in China (2018-2019)
Table 141. Key Players Revenue of Rare Disease Drug in China (2018-2019) (USD Million)
Table 142. Global Rare Disease Drug Sales by Regions (2015-2020) (K Doses)
Table 143. Global Rare Disease Drug Sales Market Share by Regions (2015-2020)
Table 144. Global Rare Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 145. Global Rare Disease Drug Sales and Forecast by Regions (2020-2025) (K Doses)
Table 146. Global Rare Disease Drug Sales Market Share by Regions (2020-2025)
Table 147. Global Rare Disease Drug Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 148. Global Rare Disease Drug Revenue Market Share by Regions (2020-2025) (USD Million)
Table 149. North America Rare Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 150. North America Rare Disease Drug Sales Market Share by Countries (2015-2020)
Table 151. North America Rare Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 152. North America Rare Disease Drug Revenue Market Share by Countries (2015-2020)
Table 153. North America Rare Disease Drug Sales by Country (2020-2025) (K Doses)
Table 154. North America Rare Disease Drug Sales Market Share by Country (2020-2025)
Table 155. North America Rare Disease Drug Revenue by Country (2020-2025) (USD Million)
Table 156. North America Rare Disease Drug Revenue Market Share by Country (2020-2025)
Table 157. Europe Rare Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 158. Europe Rare Disease Drug Sales Market Share by Countries (2015-2020)
Table 159. Europe Rare Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 160. Europe Rare Disease Drug Revenue Market Share by Countries (2015-2020)
Table 161. Europe Rare Disease Drug Sales by Country (2020-2025) (K Doses)
Table 162. Europe Rare Disease Drug Sales Market Share by Country (2020-2025)
Table 163. Europe Rare Disease Drug Revenue by Country (2020-2025) (USD Million)
Table 164. Europe Rare Disease Drug Revenue Market Share by Country (2020-2025)
Table 165. Asia-Pacific Rare Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 166. Asia-Pacific Rare Disease Drug Sales Market Share by Countries (2015-2020)
Table 167. Asia-Pacific Rare Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 168. Asia-Pacific Rare Disease Drug Revenue Market Share by Countries (2015-2020)
Table 169. Asia-Pacific Rare Disease Drug Sales by Country (2020-2025) (K Doses)
Table 170. Asia-Pacific Rare Disease Drug Sales Market Share by Country (2020-2025)
Table 171. Asia-Pacific Rare Disease Drug Revenue by Country (2020-2025) (USD Million)
Table 172. Asia-Pacific Rare Disease Drug Revenue Market Share by Country (2020-2025)
Table 173. South America Rare Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 174. South America Rare Disease Drug Sales Market Share by Countries (2015-2020)
Table 175. South America Rare Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 176. South America Rare Disease Drug Revenue Market Share by Countries (2015-2020)
Table 177. South America Rare Disease Drug Sales by Country (2020-2025) (K Doses)
Table 178. South America Rare Disease Drug Sales Market Share by Country (2020-2025)
Table 179. South America Rare Disease Drug Revenue by Country (2020-2025) (USD Million)
Table 180. South America Rare Disease Drug Revenue Market Share by Country (2020-2025)
Table 181. Middle East & Africa Rare Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 182. Middle East & Africa Rare Disease Drug Sales Market Share by Countries (2015-2020)
Table 183. Middle East & Africa Rare Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 184. Middle East & Africa Rare Disease Drug Revenue Market Share by Countries (2015-2020)
Table 185. Middle East & Africa Rare Disease Drug Sales by Country (2020-2025) (K Doses)
Table 186. Middle East & Africa Rare Disease Drug Sales Market Share by Country (2020-2025)
Table 187. Middle East & Africa Rare Disease Drug Revenue by Country (2020-2025) (USD Million)
Table 188. Middle East & Africa Rare Disease Drug Revenue Market Share by Country (2020-2025)
Table 189. China Rare Disease Drug Sales by Type (2015-2020) (K Doses)
Table 190. China Rare Disease Drug Sales Market Share by Type (2015-2020)
Table 191. China Rare Disease Drug Revenue by Type (2015-2020) (USD Million)
Table 192. China Rare Disease Drug Revenue Market Share by Type (2015-2020)
Table 193. China Rare Disease Drug Sales by Type (2020-2025) (K Doses)
Table 194. China Rare Disease Drug Sales Market Share by Type (2020-2025)
Table 195. China Rare Disease Drug Revenue by Type (2020-2025) (USD Million)
Table 196. China Rare Disease Drug Revenue Market Share by Type (2020-2025)
Table 197. Global Rare Disease Drug Sales by Application (2015-2020) (K Doses)
Table 198. Global Rare Disease Drug Sales Market Share by Application (2015-2020)
Table 199. Global Rare Disease Drug Revenue by Application (2015-2020) (USD Million)
Table 200. Global Rare Disease Drug Revenue Market Share by Application (2015-2020)
Table 201. Global Rare Disease Drug Price by Application (2015-2020) (USD/Dose)
Table 202. Global Rare Disease Drug Sales by Application (2020-2025) (K Doses)
Table 203. Global Rare Disease Drug Sales Market Share by Application (2020-2025)
Table 204. Global Rare Disease Drug Revenue by Application (2020-2025) (USD Million)
Table 205. Global Rare Disease Drug Revenue Market Share by Application (2020-2025)
Table 206. Global Rare Disease Drug Price by Application (2020-2025) (USD/Dose)
Table 207. China Rare Disease Drug Sales by Application (2015-2020) (K Doses)
Table 208. China Rare Disease Drug Sales Market Share by Application (2015-2020)
Table 209. China Rare Disease Drug Revenue by Application (2015-2020) (USD Million)
Table 210. China Rare Disease Drug Revenue Market Share by Application (2015-2020)
Table 211. China Rare Disease Drug Sales by Application (2020-2025) (K Doses)
Table 212. China Rare Disease Drug Sales Market Share by Application (2020-2025)
Table 213. China Rare Disease Drug Revenue by Application (2020-2025) (USD Million)
Table 214. China Rare Disease Drug Revenue Market Share by Application (2020-2025)
Table 215. Direct Channel Pros & Cons
Table 216. Indirect Channel Pros & Cons
Table 217. Distributors/Traders/ Dealers List
Table 218. Customers of Rare Disease Drug
Table 219. Market Opportunities in Next Few Years
Table 220. Market Risks Analysis
Table 221. Market Drivers
List of Figures
Figure 1. Rare Disease Drug Picture
Figure 2. Global Rare Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Above 1‰ Picture
Figure 4. 0.65‰_1‰ Picture
Figure 5. Below 0.1‰ Picture
Figure 6. Rare Disease Drug Sales Market Share by Application in 2019
Figure 7. Hospital Pharmacies Picture
Figure 8. Speciality Pharmacies Picture
Figure 9. Retail pharmacies Picture
Figure 10. Others Picture
Figure 11. Global Rare Disease Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 12. Global Rare Disease Drug Sales Growth Rate (2015-2025) (K Doses)
Figure 13. Global Rare Disease Drug Sales Market Share by Manufacturer in 2019
Figure 14. Global Rare Disease Drug Revenue Market Share by Manufacturer in 2019
Figure 15. Key Players Rare Disease Drug Revenue Market Share in China in 2019
Figure 16. Global Top 5 Rare Disease Drug Manufacturer Market Share in 2019
Figure 17. Top 3 Rare Disease Drug Players Market Share in China in 2019
Figure 18. Global Rare Disease Drug Revenue Market Share by Regions in 2019
Figure 19. North America Rare Disease Drug Sales YoY Growth (2015-2025) (K Doses)
Figure 20. North America Rare Disease Drug Revenue YoY Growth (2015-2025) (USD Million)
Figure 21. Europe Rare Disease Drug Sales YoY Growth (2015-2020) (K Doses)
Figure 22. Europe Rare Disease Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 23. Asia-Pacific Rare Disease Drug Sales YoY Growth (2015-2020) (K Doses)
Figure 24. Asia-Pacific Rare Disease Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 25. South America Rare Disease Drug Sales YoY Growth (2015-2020) (K Doses)
Figure 26. South America Rare Disease Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 27. Middle East & Africa Rare Disease Drug Sales YoY Growth (2015-2020) (K Doses)
Figure 28. Middle East & Africa Rare Disease Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 29. North America Rare Disease Drug Sales Market Share by Country in 2019
Figure 30. North America Rare Disease Drug Revenue Market Share by Country in 2019
Figure 31. United States Rare Disease Drug Market Size and Growth Rate (2015-2025) (USD Million)
Figure 32. Canada Rare Disease Drug Market Size and Growth Rate (2015-2025) (USD Million)
Figure 33. Mexico Rare Disease Drug Market Size and Growth Rate (2015-2020) (USD Million)
Figure 34. Europe Rare Disease Drug Revenue Market Share by Country in 2019
Figure 35. Germany Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 36. United Kingdom Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. France Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. Russia Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 39. Italy Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. Asia-Pacific Rare Disease Drug Sales Market Share by Region 2018
Figure 41. Asia-Pacific Rare Disease Drug Revenue Market Share by Region 2018
Figure 42. China Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. Japan Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Korea Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. India Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. Southeast Asia Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 47. Australia Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. South America Rare Disease Drug Sales Market Share by Country in 2019
Figure 49. South America Rare Disease Drug Revenue Market Share by Country in 2019
Figure 50. Brazil Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Argentina Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Saudi Arabia Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Turkey Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Egypt Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 55. South Africa Rare Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 56. Global Revenue Market Share of Rare Disease Drug by Type in 2019
Figure 57. Global Revenue Market Share of Rare Disease Drug by Application in 2019
Figure 58. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
